Nephrol Dial Transplant (2002) 17: 1218-1227
© 2002 European Renal Association-European Dialysis and Transplant Association
Meta-analysis of genotype–phenotype correlation in X-linked Alport syndrome: impact on clinical counselling
Medical Clinic I, Cologne City Hospital, Cologne-Merheim, Germany
Background. Alport syndrome (AS) is a hereditary nephropathy characterized by progressive renal failure, hearing loss and ocular lesions. Numerous mutations of the COL4A5 gene encoding the 
5-chain of type IV collagen have been described, establishing the molecular cause of AS. The goal of the present study was to identify the genotype–phenotype correlations that are helpful in clinical counseling. COL4A5-mutations (n=267) in males were analysed including 23 German Alport families.
Methods. Exons of the COL4A5 gene were PCR-amplified and screened by Southern blot, direct sequencing or denaturing gradient gel electrophoresis. Phenotypes were obtained by questionnaires or extracted from 44 publications in the literature. Data were analysed by Kaplan–Meier statistics, 
2 and Kruskal–Wallis tests.
Results. Genotype–phenotype data for 23 German Alport families are reported. Analysis of these data and of mutations published in the literature showed the type of mutation being a significant predictor of end-stage renal failure (ESRF) age. The patients' renal phenotypes could be grouped into three cohorts: (1) large rearrangements, frame shift, nonsense, and splice donor mutations had a mean ESRF age of 19.8±5.7 years; (2) non-glycine- or 3' glycine-missense mutations, in-frame deletions/insertions and splice acceptor mutations had a mean ESRF age of 25.7±7.2 years and fewer extrarenal symptoms; (3) 5' glycine substitutions had an even later onset of ESRF at 30.1±7.2 years. Glycine-substitutions occurred less commonly de novo than all other mutations (5.5% vs 13.9%). However, due to the evolutionary advantage of their moderate phenotype, they were the most common mutations. The intrafamilial phenotype of an individual mutation was found to be very consistent with regards to the manifestation of deafness, lenticonus and the time point of onset of ESRF.
Conclusions. Knowledge of the mutation adds significant information about the progress of renal and extrarenal disease in males with X-linked AS. We suggest that the considerable prognostic relevance of a patient's genotype should be included in the classification of the Alport phenotype.
Keywords: Alport syndrome; genetic counseling; genotype–phenotype correlation; hereditary nephropathy; type IV collagen
Correspondence and offprint requests to: Dr Oliver Gross, Medical Clinic I, Merheim Medical Centre, Ostmerheimer Strasse 200, D-51109 Köln, Germany. Email: oliver.gross{at}uni\|[hyphen]\|koeln.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  O. Gross, M. Weber, J. W. U. Fries, and G.-A. Muller Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcome Nephrol. Dial. Transplant., May 1, 2009; 24(5): 1626 - 1630. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Liu, D Colville, Y Y Wang, P N Baird, R H Guymer, and J Savige The dot-and-fleck retinopathy of X linked Alport syndrome is independent of complement factor H (CFH) gene polymorphisms Br. J. Ophthalmol., March 1, 2009; 93(3): 379 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D Colville, Y Y Wang, R Tan, and J Savige The retinal "lozenge" or "dull macular reflex" in Alport syndrome may be associated with a severe retinopathy and early-onset renal failure Br. J. Ophthalmol., March 1, 2009; 93(3): 383 - 386. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gross Understanding renal disorders as systemic diseases: the fascinating world of basement membranes beyond the glomerulus Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1823 - 1825. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wang, H. Zhang, J. Ding, and F. Wang Correlation Between mRNA Expression Level of the Mutant COL4A5 Gene and Phenotypes of XLAS Females Experimental Biology and Medicine, May 1, 2007; 232(5): 638 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Wilson, H.-S. Yoon, R. J. Walker, and M. R. Eccles A novel Cys1638Tyr NC1 domain substitution in {alpha}5(IV) collagen causes Alport syndrome with late onset renal failure without hearing loss or eye abnormalities Nephrol. Dial. Transplant., May 1, 2007; 22(5): 1338 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gross, E. Schulze-Lohoff, M.-L. Koepke, B. Beirowski, K. Addicks, W. Bloch, N. Smyth, and M. Weber Antifibrotic, nephroprotective potential of ACE inhibitor vs AT1 antagonist in a murine model of renal fibrosis Nephrol. Dial. Transplant., July 1, 2004; 19(7): 1716 - 1723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Hudson, K. Tryggvason, M. Sundaramoorthy, and E. G. Neilson Alport's Syndrome, Goodpasture's Syndrome, and Type IV Collagen N. Engl. J. Med., June 19, 2003; 348(25): 2543 - 2556. [Full Text] [PDF]
|
|
|
|
|
|
O. Gross, K.-O. Netzer, R. Lambrecht, S. Seibold, and M. Weber Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndrome Nephrol. Dial. Transplant., June 1, 2003; 18(6): 1122 - 1127. [Abstract] [Full Text] [PDF]
|
|